The company will report its earnings for FY 2016 on 01/24/2017. Generally, the company reports earnings worse than estimates. In recent months, the analysts from Thomson Reuters consensus have revised their EPS estimates downward.
Annual earnings per share is expected at 9.45 SEK for 2016 (+ 86.2% from 2015). A summary of annual publications and estimates is available below.
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Companyâs activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
PROBI AB 
